StockData
Cosmos Health Inc. logo

Cosmos Health Inc. (COSM) stock

COSMNasdaqWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 18, 2026Score 4/30107% above fair value
$2.85+0.36 (+14.46%)

Close on Nov 17, 2026Market cap $286.81MP/E –Yield –

Earnings

Cosmos Health's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue, Q3 FY2026
$17.40M
+1.7% on a year earlier
Adjusted EPS, Q3 FY2026
–
-$0.02 a year earlier
Latest guidance
Issued
Oct 9, 2026 · 1 item

Quarterly results

Revenue and earnings per share from each of Cosmos Health's earnings releases, newest first

QuarterReportedRevenueYoYEPSAdj. EPSSource
Q3 FY2026ended Sep 30, 2026Oct 9, 2026after the close$17.40M+1.7%––Release
Q2 FY2026ended Jun 30, 2026Aug 20, 2026after the close$18.99M–––Release
Q1 FY2026ended Mar 31, 2026May 22, 2026during market hours$17.93M–––Release
Q3 FY2025ended Sep 30, 2025Nov 17, 2025after the close$17.11M–-$0.17-$0.02Release
Q3 FY2023ended Sep 30, 2023Nov 22, 2023during market hours$12.80M+6.7%––Release
Q2 FY2023ended Jun 30, 2023Aug 15, 2023after the close$12.36M-6.4%–$0.01Release
Q1 FY2023ended Mar 31, 2023Apr 18, 2023before the open––––Release
Q3 FY2022ended Sep 30, 2022Nov 16, 2022after the close$12.00M–––Release
Q2 FY2022ended Jun 30, 2022Aug 23, 2022after the close$13.21M–––Release
Q1 FY2022ended Mar 31, 2022May 18, 2022before the open––––Release
Q1 FY2021ended Mar 31, 2021May 18, 2021before the open––––Filing
Q3 FY2020ended Sep 30, 2020Nov 17, 2020after the close––––Filing

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Cosmos Health's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
gross annual revenueFY2026$180.00M–NewNov 22, 2023
revenueFY2026$90.00M–NewOct 9, 2026
annual EBITDAnon-GAAPFY2026$20.00M–NewNov 22, 2023

Guidance history

Every forecast Cosmos Health put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Oct 9, 2026revenueFY2026$90.00MNew
Nov 22, 2023annual EBITDAFY2026$20.00MNew
Nov 22, 2023gross annual revenueFY2026$180.00MNew

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Cosmos Health filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Results
  3. Results
  4. Results
  5. Update
  6. Results
  7. Results
  8. Results
  9. Update
  10. Update
  11. News
  12. Update
  13. News
  14. News
  15. News

See a number that looks wrong?